Introduction Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around …
M Gianfrancesco, KL Hyrich, S Al-Adely… - Annals of the …, 2020 - ard.bmj.com
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly understood. The aim was to examine demographic and clinical factors associated with …
KM D'Silva, N Serling-Boyd, R Wallwork… - Annals of the …, 2020 - ard.bmj.com
Objective To investigate differences in manifestations and outcomes of coronavirus disease 2019 (COVID-19) infection between those with and without rheumatic disease. Methods We …
Background Over the month of April, Spain has become the European country with more confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of …
E Seyahi, BC Poyraz, N Sut, S Akdogan… - Rheumatology …, 2020 - Springer
We hypothesized that patients with rheumatic diseases (RD) would have increased psychological distress during the COVID-19 outbreak; therefore, assessed their …
ML Peral-Garrido, I Calabuig… - Annals of the …, 2021 - ard.bmj.com
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has changed life significantly worldwide. Rheumatologists also had to get used to the new …
M Putman, YPE Chock, H Tam, AHJ Kim… - Arthritis & …, 2021 - Wiley Online Library
Objective Antirheumatic disease therapies have been used to treat coronavirus disease 2019 (COVID‐19) and its complications. We conducted a systematic review and meta …
Objective To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on rheumatology practice. Method A cross-sectional web survey was designed by the members …
Aim To evaluate the impact of the coronavirus disease 2019 pandemic (COVID‐19) on the access to rheumatology care for patients with chronic rheumatic diseases (CRD) in the Arab …